This is part of a four-part series exploring the four facets of the ProShares MSCI Transformational Changes ETF (NYSEARCA:ANEW) ETF: The Future of Work, Genomics and Telehealth, the Digital Consumer and the Food Revolution. Click on other themes where linked to read other installments.
Healthcare has come a long way over the course of human history, but this may be one of the most exciting times in the sector and theProShares MSCI Transformational Changes ETF (NYSEARCA:ANEW) lets investors make their bet on those exciting developments.
Some of these changes are highly technical in nature. For instance, genomics combines our increasingly deep and complex knowledge of human biology with the sheer data-crunching power of technological advances to enable us to understand how a persons genes work and to use that to heal them.
Others are a lot closer to home. The Covid-19 pandemic has made traveling to the doctors office even more awkward and troublesome than before.As taken from ProShares information on the ANEW ETF, According to an April 2020 Harris Poll, 32% of Americans have used telehealth services, doubling since before the outbreak. The shift to telehealth may endure. Indeed, a May 2020 McKinsey & Company study stated that up to $250 billion of current U.S. healthcare spending could potentially be virtualized post-pandemic.
And thats not all. From targeted therapeutics to molecular diagnostics, ANEW digs deep into the cutting edge of the healthcare sector and pulls some of its best prospects together into one fund for investors.
The fund charges an 0.45% expense ratio, or $45 per $10,000 invested annually.
I had a chance to discuss the ANEW ETF with Scott Helfstein, Executive Director of Thematic Investing for ProShares, and talk about how ANEW is letting investors get in on cutting-edge medical advancements.
InvestorPlace: Gene editing can sound scary to some people, but its a market that continues to grow gene editing is expected to grow at a CAGR of 16.6% through 2027, to reach $6.6 billion. What are some of the use cases for this therapy investors might be more familiar with?
Scott Helfstein, Executive Director of Thematic Investing for ProShares: The search for a COVID-19 vaccine is one very salient example right now. Leading vaccine candidates from Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE)/Biontech (NASDAQ:BNTX), and other companies use genetic therapy through messenger RNA that essentially delivers photocopied blueprints. This is remarkable, representing a possible turning point in medicine and potentially the first time that genetic medicine is administered at mass scale. The technology could someday be adapted to teach the body to fight off a range of pathogens from cancer to HIV.
The COVID gene-based vaccines are specific sections or strands of genetic code manipulated to include instructions for the human body to produce antibodies capable of fighting off the virus. The vaccine does not edit peoples DNA, an individuals unique code, but uses genetic material as a delivery mechanism. Teaching the body to fight off disease directly by offering instructions at a genetic level is different than using medicine that directly attacks the pathogen or exposes the body to produce an immune response. Companies in ANEW such as Moderna and Novavax (NASDAQ:NVAX) have been exploring mRNA treatment for other areas as well.
There are few examples where treatment focuses on editing underlying human DNA or an individuals core genetic code, but this is still early in development. In 2019, a doctor in China introduced a genetic treatment to human embryos aiming to make twin girls immune to HIV. While this may sound like science fiction, there is a strong possibility that doctors will be able to actually cut out genetic code associated with diseases, perhaps even degenerative diseases like Alzheimers, and replace those genes with healthy code. This type of direct manipulation could play an important role in preventative treatment with companies like CRISPR (NASDAQ:CRSP), Invitae (NYSE:NVTA), and Editas (NASDAQ:EDIT) leading the way.
InvestorPlace: Telehealth has become a vital component of the current healthcare landscape. Obviously the Covid-19 pandemic impacted that transition, but what do you see as the future of this space? What are the companies that stand to particularly benefit?
ProShares:The adoption of Telemedicine is an excellent example of a transformational change in motion before the pandemic that has been accelerated by COVID-19. Can you imagine people actually heading back to their doctors to sit in crowded waiting rooms in future flu seasons? McKinsey reports that in 2019, 11% of U.S. consumers reported use of Telemedicine or Virtual Care services. More recently, 76% of respondents say they are moderately or highly likely to use telehealth going forward
The interesting part is that technology to support telehealth has been in place for years. There were two impediments prior to the pandemic, and COVID appears to have mowed them over. The first is related to policies around reimbursement, as both government and private insurance were not sure how to treat telemedicine. The second was doctor and patient behavior, with both hesitant to take the relationship online. Both of those impediments are may be a thing of the past.
With widespread adoption of video conference for activities from work to family holidays and happy hours, much of the U.S. population has gotten comfortable with communication technology. Telehealth can improve efficiency in healthcare. Teladoc (NYSE:TDOC) has been one beneficiary of the shift to telehealth. The company recently raised its guidance to project 2020 earnings of almost $100 millionmore than triple 2019s results.Medical device makers, such as Abbott Laboratories (NYSE:ABT), that provide instruments continuously monitoring patients are integral to meeting the demand for remote care, as well.
InvestorPlace: Data is vital to healthcare, and big data advances are helping grow the world of genomics. What are some of the leaders in the space, and what does the growth ramp for that area look like?
ProShares:Advances in biotechnology and genomics are in large part due to innovations in data analysis as well as biology. That cannot be overstated. The human genome consists of 20,000 pairs of amino acids, which would amount to a stack of 8.5 x 11 paper that was 200 feet tall. That is a twenty-story building. Biological science plays an important part, but analyzing these massive datasets is critical as well. That is just one example of data in medicine, and not even the low-hanging fruit.
Improving data access, quality, and analytics could help build a more efficient healthcare system from hospitals to individual medical practices. The healthcare industry is estimated to produce 5% of world data, but sector remains one of the least digitized. There is tremendous opportunity to leverage data for supply chain management, imaging, medical alerts, predictive analytics, new therapies, and process optimization. Veeva Systems (NYSE:VEEV), for example, is a cloud-based platform that attempts to streamline data access. IBM has also focused the Watson artificial system on cancer diagnosis. The computer is capable of reading more scans than any doctor can ever see in the course of their lifetimes, and the computer can identify or infer patterns that would otherwise be impossible for humans, hopefully then increasing the diagnostic accuracy.
InvestorPlace: The growth of targeted therapeutics is allowing for better cancer treatments with fewer adverse effects, as compared to typical treatments like chemotherapy and surgery. Do you see more companies breaking into the space? And how far do you expect the sector to expand?
ProShares:Targeted therapeutics or treatments customized based on both patient and disease characteristics, as you note, are increasingly common in cancer treatment. The idea is that targeted or personalized treatment will more effectively address a harmful disease specifically as opposed to traditional therapies targeting all rapidly reproducing cells. An increased emphasis on personalized medicine, which is critically reliant on data analysis, offers the possibility of better patient outcomes delivered more efficiently at lower cost. This is another area in healthcare we believe is still in early stages with significant growth ahead.
There are two main considerations. First, the treatment can be developed to have an optimal impact on diseased tissue while limiting the impact on the rest of the body. Second, drug development should be faster and cheaper since treatments need not be effective or even safe for all people provided they are only administered to those patients most likely to respond well. That could translate to billions in drug development savings. Quark is an interesting example of a company pushing the limits in the field.
InvestorPlace: Molecular diagnostics tests have supplanted a number of traditional testing methods, and have increased accuracy and speed of diagnoses. Can you discuss that?
ProShares:Its startling to hear the term rapid PCR test enter the mainstream media, but this reflects the importance molecular diagnostics which uses genomic scienceto testing for an illness as challenging as COVID-19.
Several hundred diagnostics have been submitted to the World Health Organization for the identification of the novel coronavirus, but only a few dozen of these have been approved for use by major healthcare authorities. Companies like Abbott Laboratories and Roche Diagnostics have seen their tests approved for use in several countries. A smaller company like Twist Bioscience (NASDAQ:TWST) is another example of an innovator in the field.
InvestorPlace: This intersection of science, tech and healthcare is of growing interest to investors. Which subsections and companies should investors be the most excited about in the next 3-5 years?
ProShares:There is a reasonable possibility that we are at the rebirth of healthcare along the lines of Hippocrates or Galen. A decade from now, we may look back and see medicine of late 20thcentury as the dark ages. The combination of genomic technology, diagnostic data, and targeted therapeutics, all powered by advanced data analysis, opens the possibility of preventive medicine and minimally invasive treatment while optimizing patient outcomes. There is a lot to be excited about based on market size and the time to deployment.
Genomics is really fascinating, and maybe a little scary. Delivery of treatment through genetic material like the some of the COVID vaccines as well as human gene editing hold tremendous potential. Companies like Moderna and Novavax have already made great strides in possibly bringing genomic treatment mainstream. COVID accelerated this transition. Editing the human genome is still in early stages but offers the possibility of treating diseases once thought almost incurable. Gene editing companies CRISPR, Editas, and Invitae hold some of the most valuable patents in the field.
On the date of publication, Jessica Loder did not have (either directly or indirectly) any positions in the securities mentioned in this article.
In The InvestorPlace Q&A, weinvite a manager to speak directly to Main Street investors, whether discussing their firms technologies, strategies or investments for the year ahead. Our goal is to put the spotlight on fund managers and other institutional investors of note, providing a detailed look into their management styles, world views and investing strategies.Read past interviews here.
See the rest here:
The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF - InvestorPlace
- Preventive or Preventative: Is There a Difference? - Merriam-Webster - January 21st, 2023
- Nurses: The Frontlines of Preventative Care - Bradley University Online - November 24th, 2022
- Functional Medicine of Idaho | Preventative Root Cause Medicine - October 29th, 2022
- This Indigenous Scientist Helped Save Lives as Covid Devastated the Navajo Nation - Scientific American - October 13th, 2022
- As governor calls for better mental health services, Healthy Wyoming says Medicaid expansion needed - Oil City News - October 13th, 2022
- Clinisys formed to help companies manage 'revolution' of lab science - OutSourcing-Pharma.com - October 13th, 2022
- Ainos Announces Positive Results from Additional Preclinical Study of Its Low-dose Oral Interferon Formulation Against New Variant Virus - Omicron -... - October 4th, 2022
- North Korea tells officials that 350,000 people died of diseases this year - Radio Free Asia - October 4th, 2022
- Episode 45 - Preventative Medicine: the Mediterranean Diet and the ... - September 25th, 2022
- Women's health got worse in 2021, global survey finds - WXOW.com - September 25th, 2022
- Wolf Creek PCN expands programming geared to health improvement - Lacombe Express - September 25th, 2022
- 1 in 10 Adults and 1 in 5 Teens Have Symptoms of Depression, What We Know - Healthline - September 25th, 2022
- Three tips to keep youth athletes in top nutritional shape this school year - The Philadelphia Inquirer - September 25th, 2022
- A blood test that detects cancer without symptoms could be a game changer for Louisiana - NOLA.com - September 25th, 2022
- Eric Idle on Surviving Pancreatic Cancer - TIME - September 25th, 2022
- Attacks on hospitals and healthcare in Ukraine: Joint Submission to the United Nations Independent International Commission of Inquiry on Ukraine,... - September 25th, 2022
- Spending on Food and lifestyle for preventive wellness is better than spending on medicines and treatment - The Financial Express - September 25th, 2022
- Exercise is Preventative Medicine - myBurbank.com - September 16th, 2022
- Best preventative medicine, health screening and anti-ageing clinics for HNWs in 2022 - Spear's WMS - September 16th, 2022
- The high hospital bills we make victims of rape and sexual violence pay - Vox.com - September 16th, 2022
- Press Release: CHMP recommends approval of Beyfortus (nirsevimab) for prevention of RSV disease in infants - StreetInsider.com - September 16th, 2022
- Why Now is the Time to Double Down on Virtual Care - HIT Consultant - September 16th, 2022
- Pickleball injuries are on the rise: 5 preventive tips to keep you on the court - The Manual - September 16th, 2022
- Opinion: From the Great War to the pandemic, doctors and nurses have always carried a heavy burden - The Globe and Mail - September 16th, 2022
- Can Sustainable Initiatives Benefit Your Team's Mental Health As Well As The Environment? - MinuteHack - September 16th, 2022
- Management of Chronic Migraine in Children and Adolescents | PHMT - Dove Medical Press - September 16th, 2022
- Workshop on promotion of physical activity in pregnancy | JMDH - Dove Medical Press - September 16th, 2022
- Men at The Emeline: how preventative medical care can help keep you on track - Australian Jewish News - August 30th, 2022
- Study: PCPs Need 26.7 Hours Per Day to Provide Recommended Care - Healthcare Innovation - August 30th, 2022
- New Guidelines Target Preventing Obesity In Midlife Women, But The Conclusion Is Somewhat Controversial - Suggest - August 30th, 2022
- Colleges need to prepare for monkeypox to spread among students, infectious disease experts say - PhillyVoice.com - August 30th, 2022
- BHERC Presents Its First Health Matters Film Screening and Panel Focused on Mental Health During The 28th Annual African American Film Marketplace and... - August 30th, 2022
- The Antitumor Effects of Quercetin - The Epoch Times - August 30th, 2022
- Why 4mg of folic acid will dramatically reduce the risk of birth defects during pregnancy - iNews - August 22nd, 2022
- Cure Is An Absolute, But Prevention Is The Ideal Vasanthi Ramachandran - CodeBlue - August 22nd, 2022
- GET PREPPED FOR A HEALTHY AND PRODUCTIVE SCHOOL YEAR - PR Newswire - August 22nd, 2022
- Researchers examine link between pesticides and thyroid cancer risk in Central California area - EurekAlert - August 22nd, 2022
- 5 Ways Your Body Is Telling You That You Need More Potassium, According to a Cardiologist and a Dietitian - Well+Good - August 22nd, 2022
- Restore Hyper Wellness Announces First Half of 2022 Performance Results with Over $60M in System-Wide Sales & Official Announcement of its Medical... - August 22nd, 2022
- Quest Diagnostics Aims to Close Gaps in Maternal Healthcare with New Obstetrics Test Panel that Includes Hepatitis C Screening - PR Newswire - August 22nd, 2022
- Flu Viral: Here Are The Most Common Queries Answered - NDTV - August 22nd, 2022
- Letters to the Editor, Aug. 19, 2022 - Toronto Sun - August 22nd, 2022
- Gambia: How Covid-19 vaccine contributes to the immunization of the most vulnerable - - Voice Gambia Newspaper - August 22nd, 2022
- The Effect of Maintenance Treatment with Erdosteine on Exacerbation Tr | COPD - Dove Medical Press - August 22nd, 2022
- Diagnostic Robotics has AI catching health problems before they take you to the ER - TechCrunch - August 14th, 2022
- Roches Xofluza issued FDA approval to treat influenza in children aged five years and older - PMLiVE - August 14th, 2022
- Ananta Medicare Provides Preventative Health Solutions to the World - PR Newswire - July 19th, 2022
- 5 "Health Tips" That are Terrible for Over 50s Eat This Not That - Eat This, Not That - July 19th, 2022
- 'Death Cap' Mushrooms Pose Threat to Dogs - University of Wisconsin School of Veterinary Medicine - University of Wisconsin School of Veterinary... - July 19th, 2022
- What Medicaid expansion means for new moms in Virginia - CBS 6 News Richmond WTVR - July 11th, 2022
- Healthcare for the Busy Bee - Flathead Beacon - July 11th, 2022
- The COVID BA.4 and BA.5 subvariants are highly transmissible. Here's what else people in CT need to know. - CT Insider - July 11th, 2022
- NHS to test using drones to fly chemotherapy drugs to Isle of Wight - The Guardian - July 11th, 2022
- The Role of Smoking and Body Mass Index in Mortality Risk Assessment for Geriatric Hip Fracture Patients - Cureus - July 11th, 2022
- Family Health Care Atlanta | Primary & Preventative Medicine - July 3rd, 2022
- Preventative medicine in Rochester Hills MI - July 3rd, 2022
- Joan Merriam: Prevention is the best medicine - The Union - June 22nd, 2022
- RIVERVIEW PRIMARY CARE PROVIDERS AVAILABLE TO OVERSEE YOUR HEALTH NEEDS - kroxam.com - June 22nd, 2022
- Prevention is the best medicine | Caseys Corner - Oroville Mercury-Register - June 22nd, 2022
- With Father's Day in mind, Mayo Clinic doctors remind men to be mindful of their health - WQOW TV News 18 - June 22nd, 2022
- Vilcek-Gold Award for Humanism in Healthcare will be presented this fall to Health Equity Leader Dr. Mona Fouad - City-sentinel - June 13th, 2022
- Margolius named Cleveland director of public health - Cleveland Jewish News - June 13th, 2022
- Three things to know about COVID-19 at this time: Dr. Robert A. Salata - cleveland.com - June 13th, 2022
- Remission seen in every rectal cancer patient in small study of drug - The Hill - June 13th, 2022
- University of Vermont: Advancing healthcare through impactful medicine - Study International News - June 13th, 2022
- On Three Different Continents, Rural Health Strains under the Weight of the Coronavirus - Scientific American - June 13th, 2022
- Do You Suffer from Knee Pain Due to Inflammation or Arthritis? Taking More Walks Will Help, a New Study Shows - Yahoo Life - June 13th, 2022
- Benign Breast Lumps | Health, Medicine and Fitness | siouxcityjournal.com - Sioux City Journal - June 13th, 2022
- 'We are definitely missing cases:' Just a fraction of COVID-19 cases reported in Washington - KING5.com - June 13th, 2022
- Flea-borne typhus outbreak puts three Aucklanders in hospital - Stuff - June 13th, 2022
- Promoters of Preventive Health A Key Role in Nursing - wknd. - May 15th, 2022
- What we know (and don't know) about North Korea's Covid outbreak - WREX.com - May 15th, 2022
- Metabolic Health and Skin Care: What to Know - WWD - May 15th, 2022
- VERIFY Fact Sheet: COVID-19 treatments - VERIFYThis.com - May 15th, 2022
- Twitter: AI applications in healthcare and more - Pharmaceutical Technology - May 15th, 2022
- How Jefferson Health is harnessing philanthropy to address health disparities - Becker's Hospital Review - May 15th, 2022
- Digital Health Companies Bring Paradigm Change Across the Health... - Healthcare Tech Outlook - May 15th, 2022
- We all have a heros journey and our job is to triumph over our tragedies - Kitimat Northern Sentinel - May 15th, 2022
- Doctor Reveals How Woke Activists Have Infiltrated Medicine - Daily Signal - May 15th, 2022
- Study: Serious COVID-19 Outcomes Are More Likely Among Unvaccinated With Heart Issues - Pharmacy Times - May 15th, 2022